[Hypothyroidism of central origin corrected by the cessation of Triac therapy].
The association of a diffuse goiter, hypothalamo-hypophyseal hypothyroidism and iodine saturation led to the reinterrogation of an obese patient who admitted taking Triac in order to lose weight. On withdrawal of this drug, the thyroid hormones and TRH test returned to normal. Triac can therefore induce reversible hypothalamo-hypophyseal hypothyroidism.
D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D007037:Hypothyroidism / Q000139:chemically induced*; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy; D013963:Thyroid Hormones / Q000097:blood; D013972:Thyrotropin / Q000097:blood; D014284:Triiodothyronine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D013963:Thyroid Hormones; D014284:Triiodothyronine; C010642:3,3',5-triiodothyroacetic acid; D013972:Thyrotropin
Hypothyroïdie d'origine centrale réversible à l'arrêt d'un traitement par Triac.